PEG Application Experiences to Geriatric Patients

Completed

• Conditions: Nutrient Deficiency; Gastrostomy

• Registration Number: NCT05110235
• Lead Sponsor: Okan University

Brief Summary

Percutaneous endoscopic gastrostomy (PEG) is currently the chosen minimally invasive, endoscopic procedure for medium- and long-term enteral feeding in cases who need palliative care. The presented study evaluated geriatric (\> 65-year-old) PEG-applied patients at our institution.

Detailed Description

Palliative care is a treatment method that focuses on the patient and patient's family, aims to minimize the complaints caused by chronic diseases that cannot be treated, and increases life quality. The National Institute for Health and Care Excellence defines palliative care as; the active, holistic care of patients with an advanced progressive illness. Management of pain and other symptoms and providing psychological, social, and spiritual support is paramount. Anorexia, weight loss, and sarcopenia are highly visible and distressing reminders of the life-limiting disease's influence on patients who require palliative care. Given this multifaceted and significant role, it is not unexpected that nutritional treatment method choices can be challenging.

Percutaneous endoscopic gastrostomy (PEG) is a minimally-invasive endoscopic procedure that creates a passage from the patient's stomach to the abdominal wall via a feeding tube and provides a means of feeding if oral intake is not adequate. This safe and effective minimally-invasive option has been utilized in medical practice for over 40 years. PEG has advantages such as being minimally invasive, causing a low rate of complications and morbidity, and providing a long-lasting and safe feeding route. It is currently the chosen procedure for medium- and long-term enteral feeding in cases who need palliative care.

The application of PEG in geriatric-palliative care has not been well discussed. With the development of endoscopic procedures and PEG devices, this minimally invasive method can be applied more safely, even in challenging cases. This study discuss the indications of PEG in the field of palliative care of geriatric patients.

Study Timeline

• Study Start: 2017-12-01
• Primary Completion: 2021-03-30
• Study Completion: 2021-05-30
• Status Verified: 2021-10
• Study First Submitted: 2021-10-13
• Study First Submitted QC: 2021-10-26
• Last Update Submitted: 2021-10-26
• Study First Posted: 2021-11-05
• Last Update Posted: 2021-11-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 52

Inclusion Criteria

PEG applied >65-year-old patients at our institution between December 2017 and March 2021 -

Exclusion Criteria

We excluded the patients who were not treated in our palliative care center

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hemoglobin (gr/dl)	30 days	30 th day hemoglobin levels after PEG application
Albumin (gr/dl)	30 days	30 th day albumin levels after PEG application

Trial Locations

Locations (1)

Okan University Hospital; 🇹🇷 Istanbul, Turkey